未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial静脉注射脑穿透性胰岛素受体抗体-iduronidase融合蛋白 (valanafusp alpha) 52周后,严重I型粘多糖贮积症患儿的神经认知和体细胞稳定: 一项开放标签1-2期试验
Giugliani, Roberto; Giugliani, Luciana; Poswar, Fabiano de Oliveira; Donis, Karina Carvalho; Dalla Corte, Amauri; Schmidt, Mathias; Boado, Ruben J.; Nestrasil, Igor; Nguyen, Carol; Chen, Steven; Pardridge, William M.
分享
收藏
分享
收藏
分享
收藏
分享
收藏Safety and clinical efficacy of AGT-181, a brain penetrating human insulin receptor antibody-iduronidase fusion protein, in a 26-week study with pediatric patients with mucopolysaccharidosis type I
Giugliani, Roberto; Giugliani, Luciana; Corte, Amauri Dalla; Poswar, Fabiano; Donis, Karina; Schmidt, Mathias; Hunt, Douglas; Boado, Ruben J.; Pardridge, William M.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏